Affiliation: Monash University, Central Clinical School, Department of Diabetes

Dr. Abdul Waheed Khan is a National Heart Foundation funded Research Fellow within the Department of Diabetes, Monash University, Australia. He is a current member of the executive of the Australian Atherosclerosis Society. He is also the founder and first president of the “Society for Research in Medicine (SRMed). SRMed is a society run by early to mid-career medical researchers that aims to disseminate research knowledge firsthand directly from researchers to the general public in simple language.  

Dr. Khan graduated with a master’s degree from the Baker Heart and Diabetes Research Institute in 2009 and worked on the role of B2 B cells in atherosclerosis. He undertook his PhD on the role of MeCP2 in the silencing of the Norepinephrine transporter gene in Postural Tachycardia Syndrome (POTS). After his PhD, he was awarded a scholarship to conduct postdoctoral training in the Karolinska Institute, Sweden. His postdoctoral studies identified critical epigenetic changes associated with microvascular function in elderly with increased cardiovascular risk. He was also awarded highly competitive early career research grants during his postdoctoral training.

In his current position, Dr. Khan aims to study the epigenomics of diabetes associated atherosclerosis. His work on the epigenetic mechanisms in diabetes associated atherosclerosis promises to be an exciting new area in cardiovascular research.